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Background: Staphylococcus aureus fibronectin-binding protein A (FnBPA) binds fibronectin and fibrinogen at adjacent
sites.
Results: The fibrinogen-binding mechanism is similar but not identical to homologous bacterial proteins. Ternary complex
formation by intact fibronectin and fibrinogen on adjacent FnBPA sites could not be demonstrated.
Conclusion: Fibrinogen binding is sterically regulated by fibronectin binding.
Significance: Steric regulation might result in targeting of S. aureus to fibrin clots.
The adjacent fibrinogen (Fg)- and fibronectin (Fn)-binding
sites on Fn-binding protein A (FnBPA), a cell surface protein
from Staphylococcus aureus, are implicated in the initiation and
persistence of infection. FnBPA contains a single Fg-binding
site (that also binds elastin) andmultiple Fn-binding sites. Here,
we solved the structure of the N2N3 domains containing the
Fg-binding site of FnBPA in the apo form and in complex with a
Fg peptide. The Fg binding mechanism is similar to that of
homologous bacterial proteins but without the requirement for
“latch” strand residues. We show that the Fg-binding sites and
themost N-terminal Fn-binding sites are nonoverlapping but in
close proximity. Although Fg and a subdomain of Fn can form a
ternary complex on an FnBPA protein construct containing a
Fg-binding site and single Fn-binding site, binding of intact Fn
appears to inhibit Fg binding, suggesting steric regulation.
Given the concentrations of Fn and Fg in the plasma, this mech-
anism might result in targeting of S. aureus to fibrin-rich
thrombi or elastin-rich tissues.
Staphylococcus aureus is a Gram-positive bacterium that can
cause a variety of infections ranging from superficial skin infec-
tions to severe invasive infections, such as infective endocardi-
tis (1); the emergence of antibiotic-resistant strains (2) presents
significant therapeutic challenges. Infective endocarditis is an
infection of the endocardium, often including the valves, and is
a complication of S. aureus bacteraemia (3). Infective endocar-
ditis is associated with high morbidity and mortality (4, 5), and
its development relies on interactions between S. aureus pro-
teins and host proteins. The bacterial cell surface fibronectin
(Fn)-binding4 protein A (FnBPA) has been implicated in this
infection (6). The N-terminal region of FnBPA contains three
subdomainsN1–N3;N2N3 binds fibrinogen (Fg) and elastin (7,
8) (see Fig. 1A). The adjacent repetitive region of FnBPA con-
tains multiple binding sites for Fn (Fig. 1A) (9, 10). Fn and Fg
binding has been proposed to cooperate in infective endocardi-
tis (6). FnBPA N2N3 has sequence homology with the N2N3
domains of the Fg-binding proteins ClfA (from S. aureus) (Fig.
1B) and SdrG (from Staphylococcus epidermidis); 24 and 22% of
the residues are identical, respectively. ClfA has also been dem-
onstrated to act as a virulence factor in infections such as septic
arthritis (11) and experimental endocarditis (12). In ClfA (13)
and SdrG (14), N2 and N3 both adopt an Ig-like fold; however,
both proteins lack the C-terminal Fn-binding repeats found in
FnBPA. The C terminus of SdrG contains two Cna_B (Pfam;
PF05738) domains followed by a short serine-rich sequence,
whereas ClfA lacks the Cna_B domains but has a longer serine-
rich sequence (15). To date, there is no structural information
for the N1 domain of Clfa, SdrG, or FnBPA.
Fg is a340-kDa glycoprotein comprising a dimer of hetero-
trimers of chains A, B, and  (16). Fg is present in human
blood at 2–4 g/liter (17) and, when converted to fibrin
(through the action of thrombin), plays a key structural role in
the clot (17). Binding sites for integrins (18) and growth factors
(19) within Fg are involved in hemostasis and wound healing.
ClfA (20) and FnBPA (21) both bind near the C terminus of the
most abundant fibrinogen -chain isoform A; SdrG binds the
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N terminus of the  chain (22). In binding to N2N3 of ClfA and
SdrG, the different Fg peptides each form a-strand conforma-
tion along the C-terminal strand of N3. Fg strand formation is
parallel in ClfA binding to the -chain (23) and anti-parallel in
SdrG binding (14) to the -chain. In addition to strand forma-
tion, in the SdrG/Fg interaction, a C-terminal sequence beyond
N3 binds back along N2 in a mechanism referred to as “dock,
lock, latch,” with the N2-binding sequence being the “latch”
(14). The ClfA-Fg interaction forms through a variation of this
mechanism that includes latching strand formation along N2
(23).
Fn is a glycoprotein present in a soluble dimeric form (450
kDa) in human blood plasma (0.3–0.4 g/liter) (24) or in the
form of insoluble fibrils in extracellular matrices (25, 26).
Fibronectin plays important roles in cell migration during
development and wound healing (27) and thrombosis (28).
FnBPA targets the N-terminal domain (NTD) of Fn, which is
composed of five F1modules (1–5F1). The Fn-binding region of
FnBPA comprises 363 residues and contains eleven homolo-
gous, intrinsically unstructured repeats (Fn-binding repeats
(FnBRs)), FnBPA-1 to FnBPA-11 (8, 29, 30) (Fig. 1A). At least
six FnBRs are able to bind with nanomolar affinity to the Fn
NTD (31). Each FnBR/NTD interaction occurs via an unusual
tandem-zippermechanism in which the FnBR forms an addi-
tional anti-parallel -strand along the triple-stranded -sheets
of sequential F1 modules (32, 33).
Although structural details of the Fg-FnBPA interaction have
been unknown to date, based on the ClfA/Fg peptide structure
(23) and the FnBPA-1/NTD structure (33), the Fg- and Fn-
binding sites onFnBPAare in close proximity (Fig. 1B), suggest-
ing that cooperativity (positive or negative) might be involved
in ternary complex formation. Here we solve the structure of
N2N3 from FnBPA in its apo and Fg peptide-bound forms. We
show that the latch strand is not required for Fg peptide or FgD
(a protolytic fragment of Fg) binding and that only a minimal
conformational change occurs in FnBPA on peptide binding.
We show that although the Fg-binding site and themost N-ter-
minal Fn-binding site on FnBPA are in close proximity, the
residues involved are nonoverlapping. However, studies using
intact Fn and Fg and their subdomains, and an FnBPA protein
construct containing the adjacent Fg- and Fn-binding sites,
provide evidence that Fg binding is sterically regulated by bind-
ing of Fn. This regulation is likely to have important implica-
tions for S. aureus interactions with host molecules in vivo.
EXPERIMENTAL PROCEDURES
Molecular Biology—Genes encoding the rFnBPA pro-
tein constructs (rFnBPA(189–511), rFnBPA(189–505), and
AF1(rFnBPA(189–550)); Fig. 1A) were subcloned from a
pQE-30 vector containing the cDNA of full-length FnBPA
(GenBankTM accession number J04151.1, S. aureus 8325-4
strain) into pET-YSBLIC-3C (34). Sequences were con-
firmed by in-house DNA sequencing.
Expression and Purification of rFnBPAs—rFnBPA constructs
were expressed with an N-terminal His6 tag in Escherichia coli
BL21 (DE3) Gold cells and purified using nickel affinity chro-
matography. The His tag was cleaved using HRV 3C protease,
and after nickel affinity chromatography to remove the tag and
uncleaved material, cleaved rFnBPAs were concentrated and
further purified by size exclusion chromatography using a pre-
packed Superdex S75 16/65 HiLoad column (GE Healthcare).
AF1 required additional anion exchange chromatography using
HiTrap Q FF Sepharose (GEHealthcare) equilibrated in 20mM
Bis-Tris buffer, pH 6.2. The purity and molecular mass of final
products were confirmed by SDS-PAGE and MS/ESI, respec-
tively. Protein concentrations were determined from absor-
bance measurements at 280 nm.
Plasma Proteins and Peptides—Intact human plasma Fg (341
kDa, product no. 341576) and FgD (a monomeric 85-kDa
proteolytic fragment of Fg containing the C-terminal regions of
A, B, and  chains, product no. 341600) were purchased
from Calbiochem-Merck-Millipore. Human plasma Fn (450
kDa, product no. F0895) and NTD (30-kDa proteolytic frag-
ment of Fn, product no. F9911), which has been shown previ-
ously to bind FnBPA-1 (31), were purchased from Sigma-
Aldrich. FgC comprising the 17 C-terminal residues of the Fg
A chain (Ac-GEGQQHHLGGAKQAGDV-NH2) was pur-
chased as a synthetic peptide from Severn Biotech Ltd.
Fibronectin-free Fg was supplied by Enzyme Research Labora-
tories (Swansea, UK).
Isothermal Titration Calorimetry (ITC)—Experiments were
performed using a MicroCal VP-ITC calorimeter (GE Health-
care) in PBS (140mMNaCl, 2.7mMKCl, 10mMNa2PO4, 1.8mM
KH2PO4, pH 7.4) at 25 °C. Procedures were similar to those
reported previously (35). Each titration started with one 2-l
injection followed by 27  10 l injections at 0.5 l/s using
6-min intervals. The stirring speed 307 rpm was used for all
titrations except those involving Fg, where the stirring speed
was increased to 321 rpm because of the higher viscosity of the
Fg solution. Binding isotherms were fitted to a single-site bind-
ing model using nonlinear regression analysis in MicroCal-Or-
igin 7.0 software.
Surface Plasmon Resonance (SPR)—Experiments were per-
formed at 25 °C using a Biacore T100 system (GE Healthcare)
upgraded to a T200 specification. Ligands in 10 mM sodium
acetate (pH 5.5) were immobilized onto the experimental flow
cell of a CM5 or C1 sensor chip (GE Healthcare) by amine
coupling and subsequent blocking (36). The reference flow cell
underwent identical but blank immobilization and blocking.
Unless otherwise stated, low level immobilizations (50–150
response units) were used. The running bufferHBS-p (10mM
HEPES, pH 7.4, 150 mM NaCl, 0.05% (v/v) polysorbate 20, GE
Healthcare) was applied at 30 l/min.
Analyte contact times were 60–300 s, dissociation times
were 180–700 s, and stabilization times were 120–1500 s.
Regenerations with low pH solutions were used only when
needed andwere optimized tominimize volume and harshness;
pre- and postregeneration binding levels and curves were com-
pared. Automated experiments were performed to measure
dissociation constants (Kd values) by kinetic or equilibrium
methods, and binding/inhibition. Five prior start-up cycles
ensured stable baselines. For Kd determination, sensorgrams
weremeasured for at least 10 sequential 2-fold analyte dilutions
to cover the concentration range 0.1Kd–10Kd. Achievement of
a steady-state response enabled Kd determination from the
equilibrium binding (37). Alternatively, kinetic data series were
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fitted to a Langmuir 1:1 binding model. Response differences
between sample and reference cells were analyzed using Evalu-
ation Software (GE Healthcare). For Kd determination, an
upper limit for analyte concentration for sensorgram analysis
was determined to ensure reliable curve-fitting indicated by low
2 values. In the binding/inhibition experiments, either AF1 or
the NTDwas immobilized; pure or mixed proteins with known
concentrations were the analytes.
Crystallography—Diffracting crystals of rFnBPA(189–505)
grew in a Clear Strategy Screen II condition containing PEG
20000 (8%, w/v), PEG monomethyl ether 550 (8%, v/v), 0.2 M
calcium acetate, with added 50 mM Tris-HCl, pH 7.4, 50 mM
NaCl, at a protein concentration of 30 mg/ml using the sitting
drop vapor diffusionmethod (38) combined withmicroseeding
utilizing Seed Bead (Hampton Research). Clusters of protein
crystals grew after 3 days at 18 °C. Clusters were transferred
into cryo-protectant (reservoir solution with additional 10%
(w/v) of PEG 20000 and 10% (v/v) of PEG monomethyl ether
550, from which a single diffracting crystal was broken off and
vitrified in liquid nitrogen.
Diffracting crystals of the FnBPA(189–505)FgC peptide
complex were grown in a Clear Strategy Screen II screen con-
dition containing PEG 2000 monomethyl ether (25%, w/v), 0.2
M calcium acetate, with added 50mMTris-HCl, pH 7.4, 100mM
NaCl, isopropanol (10% (v/v)), at an FnBPA(189–505) concentra-
tion of 25 mg/ml and a 20-fold molar excess of FgC. Sitting
drop vapor diffusion with the microseeding technique was set
up as described above. Crystals, obtained after 48 h at 18 °C,
were transferred into cryo-protectant (reservoir solution with
additional PEG 2000 (5%, w/v) and vitrified in liquid nitrogen.
X-ray Data Collection, Structure Solution, and Refinement—
Diffraction data for the rFnBPA(189–505) and rFnBPA(189–505)
FgC crystals were collected on the European Synchrotron Radi-
ation Facility (Grenoble, France) Beamline ID29 and Diamond
(UK) Beamline i04-1, respectively, at 100 K (Table 1). Diffraction
data were indexed, integrated, and scaled using HKL2000 (39)
and xia2 (40) for rFnBPA(189–505) and the rFnBPA(189–505)
FgC complex, respectively. The rFnBPA(189–505) crystal dif-
fracted to 2.19Å, and the structurewas solvedusing themolecular
replacement pipeline BALBES (41) that chose a combination of
the ClfA (Protein Data Bank code 1N67) and SdrGFg peptide
complex (ProteinData Bank code 1r17) structures as a molecular
replacement searchmodel. After initial cycles of REFMAC (42),
ARP/WARP (43, 44) was used to build a partial model. The
model was completed by the iteration of manual building in
COOT (45) and refinement by REFMAC (42). The final struc-
turewas validated usingMolProbity (46). In the Ramachandran
plot, 95.7% of residues are in the preferred region, 3.2% are in
the allowed region, and 0.9% (three residues) are outliers. The
rFnBPA(189–505)FgC crystal diffracted to 1.83 Å, and the
structure was solved bymolecular replacement using the struc-
ture of rFnBPA(189–505) as a model. The refinement and valida-
tion was carried out as described above. The Ramachandran
plot shows 96.5% of residues in the preferred region, 3.1% in the
allowed region, and 0.3% (2 residues) as outliers. The atomic
coordinates and structure factor amplitudes have been depos-
ited in the Protein Data Bank under codes 4B5Z and 4B60.
S. aureus Fn Binding Experiments—S. aureus expressing
FnBPA constructs with differing numbers of FnBRs were pro-
duced, and binding experiments to immobilized Fn were per-
formed, as previously described (47). Briefly, human plasma
fibronectin (Sigma) was diluted in PBS and immobilized onto
the plastic wells of an ELISA plate by incubation at 4 °C for 16 h.
Unoccupied binding sites were blocked with 3% bovine serum
albumin before the addition of 108 washed S. aureus cells
expressing FnBPA constructs to each well. Experiments were
done in the absence or presence of a range of concentrations of
human fibrinogen. After incubation for 1 h at 37 °C, unbound
bacteria were removed by three PBS washes. Adherent bacteria
were quantified by crystal violet staining; bound dye was solu-
bilized in 7% acetic acid, quantified by A595 measurements, and
related to bacterial numbers by reference to standard plots (45).
Binding SiteOccupancyCalculations—Relative occupancy of
the Fg- and Fn-binding sites on AF1 was calculated by consid-
ering the binding as competitive. The apparent dissociation
constant for Fg was determined according to the equation
Kd Fg, app Kd Fg (1 [Fn]/Kd Fn) (48). The average number of
Fg molecules bound per AF1molecule () was calculated using
Fg ([Fg]/(Kd app Fg [Fg])).Kd Fn,app andFn were calculated
similarly.
RESULTS
Structure of rFnBPA N2N3—Both rFnBPA(189–511) (the
N2N3domains including the latch strand) and rFnBPA(189–505)
(without themajority of the equivalent strand-forming residues
in theClfA latch; Fig. 1) were used in crystallization trials. How-
ever, only rFnBPA(189–505) produced diffracting crystals. The
structure of rFnBPA(189–505) comprises two distinct -strand-
dominated domains, N2 andN3, connected by an eight-residue
linker (Fig. 2). The N-terminal N2 domain (residues 195–335)
consists of nine -strands arranged in a sandwich of four- and
five-strand -sheets. The N3 domain (residues 344–503) has a
similar structure comprising two -sheets, each formed by five
-strands. However, unlike N2, the two -sheets within the N3
domain are linked by a short helix. The structures of N2 andN3
superimpose with a root mean square deviation (r.m.s.d.) of
3.17 Å. The structures of both domains resemble a distorted
-barrel rather than a typical -sandwich. The N2 domain
adopts the DE variant of a C-type IgG fold (DEv-IgG) identified
TABLE 1
Crystallographic data collection and refinement statistics for
rFnBPA(189–505) and the rFnBPA(189–505)FgC complex
Data for the highest resolution shell are shown in parentheses where applicable.
Parameters rFnBPA(189–505) rFnBPA(189–505)FgC
Beamline ID29 I041
Space group P212121 P1
Cell dimensions a, b, c (Å) 62.6, 75.2, 85.5 37.5, 59.1, 73.5
Cell dimensions , ,  (°) 90.0, 90.0, 90.0 91.8, 98.1, 97.9
Wavelength (Å) 0.9763 0.91731
Resolution (Å) 56.5–2.2 58.4–1.8
Rmerge 0.10 (0.52) 0.07 (0.36)
I/I 8.6 (6.0) 9.1 (2.0)
Completeness 99.2 (87.3) 93.6 (67.4)
Redundancy 6.7 (3.6) 2.2 (2.2)
No. of unique reflections 21,217 51,268
Rfactor 0.19 0.194
Rfree 0.24 0.247
Mean B-factor (Å2) 18.3 7.58
r.m.s.d. bond lengths (Å2) 0.02 0.02
r.m.s.d. bond angles (°) 1.89 1.95
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in other proteins including ClfA (13). The asymmetric unit
comprises a single copy of rFnBPA(189–505); no density was
observed for theN- andC-terminal residues (residues 189–194
and 504–505, respectively). The N2-N3 interface buries 1024
Å2 of surface area, and the main N2-N3 interdomain contacts
originate from two regions: 1) interactions between two pro-
truding loops that connect strands D and D1 within the N3
domain and the E and F strands of the N2 domain and 2) inter-
actions of the A strand of the N3 domain with a loop connect-
ing the C and D strands in the N2 domain (Fig. 2).
The Latch Strand Stabilizes Fg Binding by Only2.5-fold—It
was shown previously that the ClfA/Fg interactions are stabi-
lized 10-fold by locking of the latch strand with a disulfide
bond (23). To investigate potential stabilization provided by the
FnBPA latch strand, theKd values for interactions between FgD
and rFnBPA(189–511) or rFnBPA(189–505) (Fig. 1A) were mea-
sured using SPR (Fig. 3, A and B). FgD was immobilized on the
surface of a chip and subsequently exposed to increasing con-
centrations of rFnBPA(189–505) (Fig. 3A) orrFnBPA(189–511)
(Fig. 3B). Kd values determined from equilibrium binding data
were 3.7  0.2 and 1.5  0.1 M for rFnBPA(189–505) and
rFnBPA(189–511), respectively (Table 2). The similarity of these
Kd values demonstrates that the presence of the putative latch
strand only stabilizes the FnBPA-FgD interaction by2.5-fold.
Hence, the rFnBPA(189–505)FgC peptide complex is a suitable
minimal complex for crystallization.
Crystal Structure of the N2N3FgC Complex—The
rFnBPA(189–505)FgC complex was solved using x-ray crystal-
lography (Fig. 4A). The asymmetric unit comprises two copies
FIGURE 1. Domain composition of S. aureus FnBPA and alignment of its N2N3 amino acid sequence with ClfA, also from S. aureus. A, the domain
composition of FnBPA. Described from the N terminus, FnBPA contains a secretion signal (S) followed by the N1-N3 region and the FnBRs FnBPA-1–11. N2N3
binds fibrinogen, and the FnBRs bind the NTD of Fn. The C-terminal region contains proline-rich repeats (PRR), cell wall (W), and membrane (M) spanning
regions, a sortase A recognition motif (LPETG), and a short cytoplasmic region (C). Recombinantly expressed constructs used in this study are shown:
rFnBPA(189–505), rFnBPA(189–511), andAF1 (which contains rFnBPA(189–511) and FnBPA-1). B, alignment (ClustalW2, EMBL-EBI) of theN2N3 amino acid sequences
from FnBPA (lower rows) and ClfA (upper rows). The ClfA latch strand residues are shown in italics, and themost N-terminal residue of FnBPA-1 involved in the
interaction with the NTD from Fn is underlined (33). The potential overlap between residues affected by Fg (solid arrow) and Fn (dashed arrow) binding is
highlighted by the arrows.
FIGURE 2. Ribbon representation of the crystal structure of rFnBPA(189–505)
rFnBPA(189–505) (Fig. 1A) is colored yellow. The structures of the N2 and N3
domains are distorted -barrels and resemble the topological arrangement
of a variable IgG fold. -Strands mentioned in the text are labeled; N and C
termini are also labeled. The figure was generated using PyMOL (The PyMOL
Molecular Graphics System, version 1.4.1).
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of the rFnBPA(189–505)FgC complex, referred to as AC and
BD, which are almost identical: the r.m.s.d. between the A and
B chains was 0.33 Å). Overall, the quality of the electron density
map for the AC complex was better than that for the BD com-
plex. Although a larger proportion of the molecule could be
modeled into the AC electron density, both maps contained
clearly defined density corresponding to 14 and 12 amino acid
residues of the full-length FgC. Akin to the apo-protein struc-
ture, electron density corresponding to the N- and C-terminal
residues (residues 189–194 and 504–505, respectively) of
rFnBPA(189–505) was absent. In contrast to the apo-protein
structure, no electron density was detected within the N3 loop
(residues 479–489) that connects the F and G strands. The
FgC peptide binding site is located in a cleft between N2 and
N3. FgC forms an additional-strand parallel to the G strand
in N3 in a -zipper interaction (50). The r.m.s.d between the
structures of free and FgC-bound rFnBPA(189–505) is 0.81 Å
(Fig. 4B), confirming that binding of FgCdoes not induce large
conformational changes in the individual N2 and N3 domains
or in their relative orientation. The translocation of the N3 G
strand is the only significant change. In the apo-form, the G
strand aligns anti-parallel to the neighboring F strand. In the
FgC-bound form, the G strand “wraps” around the C-termi-
nal residues Gln-13, Ala-14, and Gly-15 of the peptide and
interacts with the N2 domain. This was also observed in the
ClfA peptide complex (23). Tyr-501 and Asn-503, which pro-
trude away from the unbound rFnBPA(189–505) structure, form
hydrogen bonds with Gly-222 and Asn-304, respectively, in
FgC-bound rFnBPA(189–505) (Fig. 4). The combined buried
surface area within the rFnBPA(189–505)FgC AC chain inter-
face is 1880 Å2.
Can AF1 Bind Fg and Fn Simultaneously?—The structure of
the rFnBPA(189–505)FgC complex and of the previously deter-
mined structures of an FnBPA-1 (Fig. 1A) peptide in complex
with 4F15F1 from the NTD of Fn (33) demonstrate that,
although nonoverlapping, the Fg-binding site on FnBPA is in
close proximity to the most N-terminal Fn-binding site
(FnBPA-1). Given that Fg and Fn are both large proteins, the
question of whether binding of one protein to FnBPA affects
the binding of the other (either though conformational change
or steric exclusion) arises (Fig. 5A). First, the ability of S. aureus
expressing FnBPA with differing numbers of FnBRs to bind to
Fn in the presence of increasing concentrations of Fg was
tested. In support of the existence of negative cooperativity
between the adjacent Fg- and Fn-binding sites on FnBPA, addi-
tion of excess Fg disrupted binding of bacteria to a Fn-coated
plate (Fig. 5B). Importantly, at the lowest concentrations of Fg,
significant inhibition of binding to Fn was only observed when
S. aureus expressing an FnBPA construct with only a single
FIGURE 3. SPR equilibrium analysis of the interactions between the ana-
lytes rFnBPA(189–505) (A) and rFnBPA(189–511) (B) with immobilized FgD.
rFnBPA(189–505) and rFnBPA(189–511) are recombinantly expressed regions of
FnBPA (Fig. 1A) and FgD, which is immobilized on the chip, is a proteolytic
fragment of Fg. Left panels, SPR sensorgrams for 2-fold dilutions of the ana-
lytes show that equilibrium is attained. Right panels, equilibrium response
differences (black squares) and steady-state affinity fit (black lines). All data
wereobtained andprocessed as describedunder “Experimental Procedures.”
The parameters derived from these experiments are shown in Table 2. RU,
response units.
TABLE 2
Summary of kinetic and thermodynamic parameters for specific
interactions
Dissociation constants (Kd values) were determined by ITC or SPR or both techniques.
Values for the enthalpy (H) and entropy (S) changes and stoichiometry (n) were also
determined for those interactions studied by ITC. Errors are from the fit.
Interaction Kd H/kcal S/cal n Method
kcal mol	1 cal mol	1 K	1
rFnBPA(189–505)/FgD 3.7 0.1 M SPRa
rFnBPA(189–511)/FgD 1.5 0.1 M SPRa
AF1/Fg 1.1 0.1 M 	6.1 0.0 6.7 2.11 ITCb
AF1/Fn 0.359 0.001 nM SPRb
AF1/FgD 1.5 0.1 M SPRb
AF1/NTD 0.393 0.002 nM SPRb
AF1/NTD 0.7 0.2 nM 	35.8 0.3 	78.1 0.89 ITCb
a The data are shown in Fig. 3.
b The data are shown in Fig. 6.
FIGURE 4. Ribbon representations of the structure of the rFnBPA(189–505)
FgC complex (A, the Fg peptide is shown in blue) and an overlay with
the apo-structure (B, yellow). The G strand of N3 and N3 residues men-
tioned in the text that adopt a different orientation on peptide binding are
highlighted. The figures were generated and the structures aligned using
PyMOL (The PyMOL Molecular Graphics System, version 1.4.1).
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FnBR (FnBPA-1) was used. When more Fn-binding repeats
were present, Fn binding plateaued at a higher level, suggesting,
asmight be expected, that only Fn binding to the FnBR adjacent
to the Fg-binding site was inhibited by Fg. To investigate this
potential negative cooperativity between Fg and Fn binding,
AF1 (Fig. 1A) a recombinant FnBPA protein construct con-
taining only the Fg (N2N3) binding site and the most N-ter-
minal FnBR (FnBPA-1), was prepared. The first step was to
measure the binding of the intact Fn and Fg and their sub-
domains to AF1.
TheKd values (Table 2) for the AF1-Fn (Fig. 6A; 0.36 0.001
nM) and AF1/Fg interaction (Fig. 6B; 1.1  0.1 M) were mea-
sured using SPR kinetic analysis and ITC, respectively. The
stoichiometry of 2:1 for the AF1/Fg interaction is consistent
with the presence of two identical binding sites on intact
dimeric Fg. The affinity of the AF1/FgD interaction (Kd 1.5 
0.1 M) was determined using SPR equilibrium analysis (Fig.
6C). The Kd for the AF1/NTD interaction was determined
using ITC (Fig. 6D) as 0.7 0.2 nM. The steep transition of the
binding curve resulted in a relatively high fit error (28%).Hence,
this interaction was alsomeasured using SPR kinetic analysis as
0.393  0.002 nM (Fig. 6E) using increasing concentrations of
the NTD as analyte and with AF1 immobilized onto a chip. Fig.
6 shows that both the Fg- and Fn-binding sites inAF1 are active.
Because theKd values for the AF1 interactions with Fg and FgD
andwith Fn andNTDare virtually identical, there appears to be
no steric occlusion of the binding sites within AF1 when indi-
vidual proteins are binding. The physiological relevance of AF1
was assessed by a plasma pulldown assay, which demonstrated
that AF1 also binds Fg and Fn under the conditions of human
plasma (data not shown). However, this experiment does not
reveal whether Fg and Fn can bind simultaneously to the same
AF1 molecule.
Fig. 7A shows, for the first time, that a subdomain of Fn
(NTD), AF1, and intact Fg can form a ternary complex. Expo-
sure of an NTD-coated chip to an AF1Fg complex (0.5 M)
generated a response exceeding 650 response units, whereas
separate injections of AF1 (0.5 M) and Fg (0.5 M) only pro-
duced responses of 50 and 0 response units, respectively. The
formation of the ternary complex was blocked by addition of
FgC. The results clearly demonstrate that AF1 can bind both
Fg and NTD simultaneously to form a ternary complex.
The binding of Fg and intact Fn to AF1 was then investigated
using SPR (Fig. 7B). An AF1-coated surface was exposed to a
solution containing either Fg (2.3, 23, and 90 M) or Fn (23 and
230 nM); binding was observed in all cases, showing that both
Fg- and Fn-binding sites were active on the chip surface. Next,
Fg and Fn were flowed over the chip together at concentrations
of 2.3 M and 230 nM, respectively. This reflects the 10:1 Fg:Fn
ratio present in human plasma (49, 50). The binding trace was
virtually identical to that observed for Fn only (at 230 nM), sug-
gesting that no Fg interacts when the AF1-coated surface is
saturated with Fn. Next, Fg (90 M) was added to a solution of
Fn (23 nM) and injected over the surface. Now the trace was
virtually identical to that given upon injection of Fg only at 90
M. This suggested that the molar excess of Fg saturated the
AF1-coated surface and blocked the AF1-Fn interaction. Thus
when intact proteins are used, it appears that no ternary com-
plex is formed. Note that when subsaturating concentrations of
Fn (23 nM) and Fg (23 M) are combined, there is an additive
response in the SPR trace that likely reflects binding of Fg and
Fn to separate AF1 molecules on the chip.
Relative Occupancy of the Fg- and Fn-binding Sites of FnBPA
in Plasma—When either Fg or Fn were present in large excess,
SPR experiments suggested that the other ligand (Fn or Fg,
respectively) could not bind (Fig. 7B) to AF1; that is, a ternary
complex comprising AF1, Fn, and Fg was not observed. If only
the affinities for the isolated binding sites in AF1 are consid-
ered, the reported concentrations of Fg (3 g/liter; 9 M) and
Fn (0.3 g/liter; 0.7 M) in plasma would lead to relative occu-
pancies of 0.89 and 1.0 for the Fg- and Fn-binding sites, respec-
tively. However, Fig. 7B suggests that Fg and Fn compete for
binding to AF1. It is possible to calculate a reduced “apparent
Kd” for binding of one protein to FnBPA in the presence of a
specific concentration of an inhibitor.When the concentration
of the two proteins in the plasma is taken into account, the
relative occupancies of the Fg- and Fn-binding sites at equilib-
rium are predicted to be 0.004 and 0.99, respectively. This sug-
FIGURE 5. The close proximity of Fn- and Fg-binding sites in S. aureus FnBPA suggests a mechanism for negative cooperativity. A, ternary complex.
Putative structure of the ternary complex formed by FgFnBPAFn. Blue, Fg; magenta, FnBPA; cyan, Fn. The model was prepared from three separate crystal
structures: rFnBPA(189–505)FgCand twomodule pairs
4F15F1 and 2F13F1 in complexwith synthetic peptides representing fragments of FnBPA-1 (ProteinData
Bank codes 2RKY and 2RKZ) (33). Both module pairs are held together by disulfide bridges (yellow). Unmodeled regions of the three proteins are shown as
colored ovals (not to scale). B, binding of S. aureus expressing various FnBPA constructs to Fn immobilized on plastic wells in the presence of increasing
concentrations of Fg in solution. Values thatwere significantly different (p
 0.05) frombinding in the absenceof soluble protein are indicatedwithasterisks.
Experiments were repeated three times in duplicate. Square, FnBPAwith only one FnBR (FnBPA-1); triangle, FnBPAwith three FnBRs 1, 10, and 11; circle, intact
FnBPA (i.e.with FnBRs 1–11).
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gests that the Fg-binding site on FnBPA is predominantly unoc-
cupied during S. aureus bacteremia.
DISCUSSION
FnBPA was previously identified as a virulence factor in
S. aureus infective endocarditis, with the Fg- and Fn-binding
sites (21) synergistically promoting infection (6, 51). This work
set out to characterize the FnBPA Fg-binding domain and its
interaction with Fg and to test whether Fg and Fn can bind
FnBPA simultaneously. Although the FnBPA/Fn interaction
has been the subject of extensive structural characterization
(31, 33, 52), no experimentally determined structure of FnBPA
bound to its target site in Fg has previously been reported.
Previous studies of Fg binding to the bacterial proteins SdrG
and ClfA revealed a mechanism of binding called dock, lock,
latch (14). In SdrG, on binding of the Fg peptide the latch (a
sequence at the C terminus of N3) forms a stabilizing strand/
strand interaction along a -strand in N2. In ClfA, the role of
the latch is less clear (Protein Data Bank code 2VR3 (23))
because the deposited Fg peptide/ClfA structure contains an
engineered disulfide bond between the latch and N2. In the
apo-structure the latch sequence was either significantly trun-
cated in themodeled structure, suggesting disorder (SdrG; Pro-
tein Data Bank code 2R19 (14)), or was stabilized by a short
strand/strand interaction along N3 (ClfA; Protein Data Bank
code 1N67 (13)). Sequence similarity betweenClfA and FnBPA,
the demonstration that the target site in Fg is the same, and that
the affinity of the interaction is similar suggest both a similar
mechanism of Fg binding for the two S. aureus proteins and a
potentially puzzling level of redundancy.
In the present study, only a construct (FnBPA(189–505)) lack-
ing the majority of the latch strand residues formed well dif-
fracting crystals, and the affinity of the interaction of FgD with
N2N3-containing constructs was reduced only 2.5-fold by
this truncation (Fig. 3). Further truncation (to FnBPA residue
498) has been previously shown to disrupt Fg and elastin bind-
FIGURE 6.BindingofAF1 to intact Fn andFgand subdomains.A, SPR sensorgram (red) and Langmuir kinetic binding fit (black) for 2-fold dilutions of dimeric
human plasma Fn (5.2–0.01 nM) binding to AF1 (Fig. 1A) immobilized on a chip. B, heat generated on ligand injection (upper panel) and best fits of binding
isotherms (lower panel) for the ITC titration of AF1 with Fg. C, SPR equilibrium binding analysis for AF1 (Fig. 1A) binding to FgD (immobilized), a proteolytic
fragment of Fg. D, ITC experiment in which AF1 (Fig. 1A) is injected into NTD, a proteolytic fragment of Fn. E, SPR sensorgrams for the interaction of NTD with
AF1 (immobilized). All data were obtained and processed as described under “Experimental Procedures.” Parameters derived from these experiments are
shown in Table 2. RU, response units.
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ing (8). However, inspection of both the previously determined
ClfA/Fg peptide structures and the FnBPA(189–505)FgC com-
plex determined here show that this truncation would remove
intradomain interactions within N3 rather than only latching
residues.
The structures of N2N3 (without latch) in isolation and in
complex with FgC revealed, as expected, similarities in the
apo-structures and in themechanism of FgC binding between
FnPBA and ClfA. Both N2 and N3 adopt Ig-like folds; N2
adopted the DEv-IgG variant described previously (13). The
structure of the complex revealed parallel -zipper binding by
the peptide along the G strand of N3 (as in ClfA) and within a
cleft formed predominantly by residues with hydrophobic side
chains, stretching between the N2 and N3 domains. Previous
studies (53, 54) suggested the C terminus of the Fg  chain is
intrinsically disordered. Thus it is likely to undergo a disorder
to order transition upon binding to FnBPA. It fits into the cleft,
causing theN3-G strand to translocate andwrap around the Fg
peptide C terminus, establishing a relatively large interface.
There are also important differences in the binding mecha-
nism compared with ClfA. Clearly, the latch -strand residues
are absent in the FnBPA(189–505)FgC structure. Rather, the
data suggest that only the first few residues of the putative latch
region (Tyr-501 andAsn-503)might be required for Fg binding.
In a recent structural analysis of N2N3 from ClfB binding to a
peptide from the Fg -chain, a latching strand interaction did
not appear to be required (55). This truncation of the mecha-
nism to dock and lock was suggested to occur because the ClfB-
binding site in the -chain of Fg is midchain rather than at the
C terminus. However, the results presented here suggest that
latching is not always required even for C-terminal Fg peptide
binding. In addition, the relative orientations of the N2 and N3
domains in FnBPA(189–505) do not change significantly upon
FgC binding, unlike in binding of ClfA to FgC.
FnBPA (containing adjacent Fg- and Fn-binding sites) repre-
sents an unusual opportunity to characterize formation of a
ternary complex. Previous structural studies of FnBPA-1 in
complexwith the Fn F1module pair 4F15F1 and the structure of
N2N3 in complex with an Fg peptide presented here clearly
show that the adjacent binding sites for Fg and Fn in intact
FnBPA are in close proximity but do not overlap. In particular,
the lack of the requirement for latching strand residues in the
FIGURE 7. Ternary complex formation and steric regulation. A, representative SPR sensorgrams show responses from the interactions of NTD (a proteolytic
fragment of Fn) immobilized on a C1 chipwith AF1 (0.5M; Fig. 1A) in the presence or absence of an equimolar concentration of Fg. The effect of FgC (50M)
on the NTDAF1Fg ternary complex is also shown. The experiments shownwere conducted sequentially on the same chip, and the order of experiments was
as follows: 0.5M AF1 0.5M Fg; 0.5M AF1 0.5M Fg 50M FgC; 0.5M Fg; and 0.5M AF1. Regeneration was achieved with low pH. Repeats of 0.5
M AF1  0.5 M Fg were performed midway and at the end of the sequence of experiments to check binding after regeneration (data not shown). B,
representative SPR sensorgrams from interactions of AF1 (Fig. 1A) with Fn and/or Fg. The experiments shownwere conducted sequentially on the same CM5
chip with immobilized AF1. The order of experiments was as follows: 90M Fg; 90M Fg 23 nM Fn; 23 nM Fn; 23M Fg 23 nM Fn; 23M Fg 230 nM Fn; 23
M Fg; 2.3 M Fg; and 230 nM Fn. Regeneration was achieved with low pH. Repeats of 90M Fg and 23 nM Fn were performed well separated in the sequence
of experiments to demonstrate reproducibility of Fg and Fn binding after regeneration (data not shown). RU, response units.
Steric Regulation of Fibrinogen Binding to S. aureus FnBPA
MAY 2, 2014•VOLUME 289•NUMBER 18 JOURNAL OF BIOLOGICAL CHEMISTRY 12849
 at A
nglia Ruskin U
niversity on N
ovem
ber 11, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
rFnBPA(189–505)/FgD interactions (Table 2) suggested larger
potential separation in the primary sequence between residues
in FnBPA directly involved in binding of Fg and those affected
by binding of Fn to the most N-terminal FnBR (FnBPA-1).
However, given that both the rFnBPA(189–505)/FgC and
FnBPA-1/4F15F1 interactions involve strand formation, the
potential for positive cooperativity through latch strand stabi-
lization adjacent to the strand-forming residues of FnBPA-1
exists (Fig. 5A). For example, positive cooperativity was
observed previously in NTD binding to adjacent FnBRs in a
streptococcal protein (56). Alternatively, steric regulation of
binding to the adjacent sites (because both intact Fg and intact
Fn are large proteins; Fig. 5A) might occur. Fig. 5B provides the
first evidence for steric regulation of the adjacent binding sites
when FnBPA is expressed on the surface of S. aureus.
Investigations at the molecular level show that the adjacent
Fg- and Fn-binding sites of FnBPA (when expressed recombi-
nantly as AF1) can form a ternary complex with Fg and the
NTD subdomain of Fn (Fig. 7A). However, in Fig. 7B in which
intact Fg and Fnwere used, ternary complex formation was not
observed. These two results together argue in favor of negative
cooperativity arising though steric exclusion. The linear, and
nonoverlapping, nature of the Fg- and Fn-binding sites in AF1
suggests that this result can be extrapolated to intact FnBPA
and provides an explanation for the inhibition observed in
Fig. 5B.
Although Fg is at a 10-fold higher concentration than Fn in
the plasma, occupancy analysis predicts that Fn binding pre-
dominates because of the higher affinity of the interaction. This
makes sense because FnBPA, although having only one
Fg-binding site, hasmultiple Fn-binding sites (31), so inhibition
of binding of Fn (by Fg) to the most N-terminal site would have
little overall affect because Fn could (presumably) bind at the
other sites unaffected by Fg binding.
Intriguingly, the binding of ClfA to Fg has been shown pre-
viously also to be negatively regulated, in this case by Ca2-
binding (57). The Ca2-binding site is not conserved in the
N2N3 domains of FnBPA, so it is interesting that a different
mechanism of negative regulation seems to present. The
importance of Fg binding (by either FnBPA or ClfA) for the
initiation of infection in infective endocarditis has been clearly
demonstrated (6, 51). How might regulation of the Fg-binding
site though steric exclusion (or Ca2 binding) aid initiation of
infection?One possibility, suggested previously byO’Connell et
al. (57) is that negative regulation of Fg binding might result in
targeting of S. aureus to solid phase fibrinogen or fibrin clots.
The C terminus of the  chain of Fg is not only present in
soluble Fg but also in cross-linked fibrin, and here it will have a
higher local concentration and may thus be able to compete
with Fn binding. S. aureus has previously been shown to bind
more effectively to fibrin than fibrinogen (58). In the case of
FnBPA where steric regulation appears to be operating, the
accessibility of the binding site is also likely to play a role. Lastly,
FnBPA also binds elastin (8) at a site that overlaps with the Fg
peptide-binding site. Elastin binding to FnBPAwas inhibited at
lower concentrations of Fg peptide than Fg binding to FnBPA
(8). Thus it is also possible that maintenance of a free binding
site in N2N3 results in targeting of bacteria to elastin-rich tis-
sues such as blood vessel walls during the initiation of infection.
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